Differential Symptom Presentation in Sexually Abused Children: PTSD vs. ADHD

Stewart, Lynn A.; Faust, Jan L.; Salter, S.; Brosbe, Micah S.; Hoefling, K.

doi:10.1037/e517292011-662

PsycEXTRA Dataset 2009

DOI: 10.1037/e517292011-662

|View full text |Cite

Differential Symptom Presentation in Sexually Abused Children: PTSD vs. ADHD

Lynn A. Stewart¹,

Jan L. Faust²,

S. Salter³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2017

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Department of Health & Human Services, 2014). The prevalence of smoking among individuals with posttraumatic stress disorder (PTSD) is particularly high, with past-year estimates around 44.6% (e.g., Acierno, Kilpatrick, Resnick, Saunders, & Best, 1996; Stewart, 2014). Smokers with PTSD not only smoke more heavily compared with smokers without PTSD, but also demonstrate greater nicotine dependence (ND) and lower quit rates following smoking cessation interventions (Feldner, Babson, & Zvolensky, 2007; Lasser et al, 2000; Moran, Sampath, Kochunov, & Hong, 2013).…”

mentioning

confidence: 99%

Concurrent varenicline and prolonged exposure for patients with nicotine dependence and PTSD: A randomized controlled trial.

Foa¹,

Asnaani²,

Rosenfield³

et al. 2017

Journal of Consulting and Clinical Psychology

View full text Add to dashboard Cite

Background Prevalence of smoking among individuals with post-traumatic stress disorder (PTSD) is disproportionately high, and PTSD is associated with especially poor response to smoking cessation treatment. Objective The current study examined whether integrating treatments for smoking cessation (varenicline plus smoking cessation counseling; VARCC) and PTSD (prolonged exposure therapy; PE) enhances smoking outcomes among smokers diagnosed with PTSD. Method 142 adults with nicotine dependence and PTSD were randomized to a treatment program consisting of varenicline, smoking cessation counseling, and PE (VARCC+PE) or to VARCC only. Seven-day point prevalence abstinence (PPA) at post-treatment (3-months post-quit day) and follow-up (6-months post-quit day), verified by serum cotinine levels and exhaled carbon monoxide, was our primary smoking outcome. Psychological outcomes were PTSD and depression severity. Mixed effects models included baseline PTSD severity as a moderator of treatment condition effects. Results Overall, VARCC+PE participants did not show greater PPA than VARCC participants. However, treatment effects were moderated by baseline PTSD severity. For participants with moderate and high PTSD severity, VARCC+PE led to significantly higher PPA than VARCC alone (ps<.05). No differences between treatment conditions emerged for participants with low baseline PTSD severity. Participants who received PE showed significantly greater reduction of PTSD and depression symptoms than those who did not receive PE. Conclusions Integrating psychological treatment for PTSD and smoking cessation treatment enhances smoking cessation for participants with moderate or severe PTSD symptom severity, but does not enhance smoking cessation for participants with low baseline PTSD severity.

show abstract

mentioning

confidence: 99%

Concurrent varenicline and prolonged exposure for patients with nicotine dependence and PTSD: A randomized controlled trial.

Foa¹,

Asnaani²,

Rosenfield³

et al. 2017

Journal of Consulting and Clinical Psychology

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Differential Symptom Presentation in Sexually Abused Children: PTSD vs. ADHD

Cited by 1 publication

References 0 publications

Concurrent varenicline and prolonged exposure for patients with nicotine dependence and PTSD: A randomized controlled trial.

Concurrent varenicline and prolonged exposure for patients with nicotine dependence and PTSD: A randomized controlled trial.

Contact Info

Product

Resources

About